Analyst Ratings for CIGNA (CI )
CI Rating Summary
CI Price Target Summary
- Highest: $400.00 (UBS)
- Lowest: $297.00 (Nephron)
- Average: $342.15
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$342.15 (+21.1%)
* Over Last 12-Mos
Rating Score: 6.6 / 10
Percentile Rank: 68%
Avg. $ Target:
$342.15 (+21.1%)
* Over Last 12-Mos
Rating Score: 6.6 / 10
Percentile Rank: 68%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/4/2026 | Jefferies | David Windley | Downgrade | Hold (Buy) |
307.00 (336.00) |
279.05 (282.49) |
1.23% | Details |
| 8/3/2026 | Raymond James | John Ransom | Downgrade | Outperform (Strong Buy) |
320.00 (350.00) |
279.05 (282.49) |
1.23% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
